ClinicalTrials.gg
RecruitingNCT06801366VIDEOUpdated Jan 7, 2026

VIdeo Clips for Diagnostic Evaluation of Obstructive Sleep Apnea in Children

An observational study in Obstructive Sleep Apnea (OSA), sponsored by Children's Hospital of Eastern Ontario. Recruiting at 4 sites in Canada. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Children's Hospital of Eastern Ontario · Observational

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
625
Ages
2 Years to 18 Years
Sex
All
01

Study summary

Obstructive sleep apnea (OSA), which occurs in 1-4% of children, is a serious condition where a person stops breathing periodically during sleep because their airway closes. Untreated, it is associated with high blood pressure, behavioural problems, and lower quality of life. While early diagnosis and treatment are critical, there are significant barriers to access to a sleep study (the best diagnostic test). Questionnaires and overnight oxygen level recordings are limited in their ability to identify OSA. Better screening tools are needed to identify and prioritize children for sleep study testing. Short video clips, recorded using smartphones by parents, may be a useful tool to identify children at risk of OSA who would most benefit from a sleep study. The study aims to evaluate the ability of home smartphone video clips as a screening tool for moderate-severe OSA in children referred for a sleep study. The utility of video clips will also be compared to questionnaires and overnight oxygen saturation recordings. The investigators believe that the video clips will be able to predict moderate-severe OSA in children and that they will be better than standard clinical questionnaires or oxygen recordings. This multi-centre study will include 625 children referred for sleep studies for suspected OSA. Parents will be asked to record short video clips of their child sleeping, which will be rated for the presence and severity of OSA. Children will then undergo a sleep study, and parents will complete a questionnaire about sleep symptoms. Oxygen level recordings will be extracted from the sleep study. The diagnostic accuracy of video clips will be determined and compared to the questionnaire and oxygen level recording. This new approach to screening for pediatric OSA using widely available technology will allow children at the highest risk for moderate-severe OSA to be diagnosed and treated earlier, minimizing the risk of long-term complications.

02

Conditions studied

  • Obstructive Sleep Apnea (OSA)

Keywords

  • obstructive sleep apnea
  • polysomnography
  • videos
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's planned enrollment of 625 is above the median of 105 across 666 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Children's Hospital of Eastern Ontario is the lead sponsor of 84 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

4 Canadian tertiary pediatric centres: Children's Hospital of Eastern Ontario (Ottawa), The Hospital for Sick Children (Toronto), Montreal Children's Hospital (Montreal), Stollery Children's Hospital (Edmonton)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 2-18 years old
  • referred for diagnostic PSG to assess for OSA at their local tertiary care centre
  • parent/caregiver has access to mobile technology

Exclusion criteria

Exclusion Criteria:

  • previous diagnosis of sleep-disordered breathing based on PSG in the last five years
  • unable to cooperate for PSG
  • clinician-suspected presence of central sleep apnea or central hypoventilation
  • genetic or congenital syndrome
  • non-verbal
  • use of PAP therapy or tracheostomy
  • parent/caregiver does not speak English or French
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
625 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children with suspected Obstructive Sleep Apnea

    Children referred for polysomnography (PSG) to investigate symptoms of obstructive sleep apnea (OSA).

    Diagnostic Test: Parent-recorded smartphone video clips

Interventions

  • Diagnostic testParent-recorded smartphone video clips

    Parents will record smartphone video clips of their child asleep, which will be scored by pediatric sleep physicians for presence of moderate-severe OSA. Children will then undergo clinically indicated polysomnography (PSG). Video clips will be evaluated for diagnostic accuracy, with PSG as the gold standard.

06

What researchers measure

Primary outcomes

  1. Diagnostic performance of video clips

    Evaluate the diagnostic accuracy of video clips compared to PSG in the detection of moderate-severe OSA. Estimate the area under the ROC curve.

    Time frame: From enrolment to end of data analysis (5 years).

Secondary outcomes

  1. Specificity of video clips

    To determine the specificity of video clips for diagnosis of moderate-severe OSA, if sensitivity is held at 0.90.

    Time frame: From enrolment until the end of data analysis (5 years)

  2. Sensitivity of video clips

    To determine the sensitivity of video clips for diagnosis of moderate-severe OSA, if specificity is held at 0.90.

    Time frame: From enrolment until the end of data analysis (5 years)

  3. The added benefit of oximetry to the accuracy of video clips

    To determine the added benefit of oximetry to the specificity and sensitivity of the video clips, if each is individually held at 0.90.

    Time frame: From enrolment until the end of data analysis (5 years)

  4. The added benefit of the Pediatric Sleep Questionnaire (PSQ) and oximetry to the accuracy of video clips

    To further determine the benefit of the PSQ in addition to oximetry and video clips in terms of specificity and sensitivity, if each is individually held at 0.90.

    Time frame: From enrolment until the end of data analysis (5 years)

07

Study locations

3 of 4 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Jul 2028, 39 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2025
First posted
Jan 30, 2025
StartActual
Mar 18, 2025
Primary completionEst.
Jul 1, 2028
CompletionEst.
Jul 1, 2029
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06801366
Lead sponsor
Children's Hospital of Eastern Ontario
Responsible party
Sherri Katz (Division Chief of Pediatric Respirology and Senior Scientist, Children's Hospital of Eastern Ontario) — Principal investigator
First posted
Jan 30, 2025
Start date
Mar 18, 2025
Primary completion
Jul 1, 2028 (estimated)
Completion
Jul 1, 2029 (estimated)
Last update
Jan 7, 2026

Study contacts

Sherri Katz
Contact
skatz@cheo.on.ca
(613) 737-7600

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion